These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice. Striano P, McMurray R, Santamarina E, Falip M. Epileptic Disord; 2018 Feb 01; 20(1):13-29. PubMed ID: 29313492 [Abstract] [Full Text] [Related]
10. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Brodie MJ, Rosenfeld WE, Vazquez B, Sachdeo R, Perdomo C, Mann A, Arroyo S. Epilepsia; 2009 Aug 01; 50(8):1899-909. PubMed ID: 19490053 [Abstract] [Full Text] [Related]
19. Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview. Wier HA, Cerna A, So TY. Paediatr Drugs; 2011 Apr 01; 13(2):97-106. PubMed ID: 21351809 [Abstract] [Full Text] [Related]
20. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan. Ohtsuka Y, Yoshinaga H, Shirasaka Y, Takayama R, Takano H, Iyoda K. Epilepsy Res; 2014 Nov 01; 108(9):1627-36. PubMed ID: 25219353 [Abstract] [Full Text] [Related] Page: [Next] [New Search]